MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 112 filers reported holding MIRATI THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,466,000 | +11.1% | 20,000 | -35.7% | 0.01% | 0.0% |
Q4 2018 | $1,319,000 | -10.0% | 31,100 | 0.0% | 0.01% | +20.0% |
Q3 2018 | $1,465,000 | -41.8% | 31,100 | -39.1% | 0.01% | -41.2% |
Q2 2018 | $2,519,000 | +34.3% | 51,100 | -16.4% | 0.02% | +30.8% |
Q1 2018 | $1,876,000 | -15.1% | 61,100 | -49.5% | 0.01% | -13.3% |
Q4 2017 | $2,210,000 | -24.8% | 121,100 | -51.8% | 0.02% | -21.1% |
Q3 2017 | $2,938,000 | +220.4% | 251,100 | 0.0% | 0.02% | +216.7% |
Q2 2017 | $917,000 | +32.5% | 251,100 | +88.7% | 0.01% | +20.0% |
Q1 2017 | $692,000 | – | 133,037 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |